Related Experiment Video
Updated: Jan 9, 2026

05:10
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
12.5K
High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive
Martin Gerard McCabe1, Koichi Ichimura, Lu Liu
1Department of Pathology, University of Cambridge, Division of Molecular Histopathology, UK. mcm41@cam.ac.uk
Journal of Neuropathology and Experimental Neurology
|June 20, 2006
Summary
Array comparative genomic hybridization (CGH) reveals novel genetic changes in aggressive childhood brain tumors. These findings distinguish medulloblastomas and supratentorial primitive neuroectodermal tumors, aiding in understanding their distinct genetic profiles.
Area of Science:
- Neuro-oncology
- Genomics
- Cancer research
Background:
- Medulloblastomas and supratentorial primitive neuroectodermal tumors are aggressive pediatric brain cancers.
- Understanding their genetic underpinnings is crucial for diagnosis and treatment.
Purpose of the Study:
- To utilize array comparative genomic hybridization (CGH) for high-resolution genomic profiling of these tumors.
- To identify novel copy number alterations and compare genomic profiles between medulloblastomas and supratentorial primitive neuroectodermal tumors.
Main Methods:
- Whole-genome array CGH was performed on 34 medulloblastomas and 7 supratentorial primitive neuroectodermal tumors.
- A BAC/PAC/cosmid array with 0.97 Mb median clone separation was employed.
- Genomic copy number changes were identified and mapped.
Main Results:
- Array CGH identified numerous novel, small regions of copy number change.
- Novel amplifications of oncogenes (MYCL1, PDGFRA, KIT, MYB) were found.
- Distinct patterns of copy number alterations were observed between medulloblastomas and supratentorial primitive neuroectodermal tumors, indicating genetic divergence.
Conclusions:
- Array CGH provides a more detailed genomic landscape of pediatric brain tumors than conventional methods.
- The identified genetic differences support the classification of medulloblastomas and supratentorial primitive neuroectodermal tumors as distinct entities.
- Findings may inform future therapeutic strategies targeting specific genetic alterations.

